Key result
In four patients with intravascular lymphomatosis, the disease showed a variable clinical course with progression and central nervous system involvement, and no consistently effective therapy.
Case Report (n=4)
Intravascular lymphomatosis is a rare malignancy with a variable clinical course and poor response to current therapies.
Raises suspicion for IVL in atypical presentations; extends sparse literature but leaves optimal therapy open.
Intravascular lymphomatosis (IVL) is a rare malignancy characterized by neoplastic proliferation of lymphoid cells within the lumens of arteries, small veins and capillaries. We report four patients with IVL and review the recent world literature, relating to incidence, clinical features and possible therapy. In these cases diagnosis was established coincidentally in one patient after prostatectomy. This patient eventually had central nervous system involvement. In two other patients IVL was diagnosed from skin lesions. In the fourth case the diagnosis was established at post-mortem examination, where involvement of most organs was evident but particularly kidneys, myocardium, gastrointestinal tract and lymph nodes. Therapy was given to three patients, but the disease progressed in two and they both died with evidence of central nervous system involvement, while the third patient has had a good partial response to combination chemotherapy but has relapsed within two months of completing chemotherapy. As evident from our patients and the literature review IVL has a variable clinical course and currently, there appears to be no effective therapy for this rare disorder.
No takes yet. Share an insight, caveat, or question.
Bogomolski-Yahalom et al. (1998) conducted a case report in Intravascular lymphomatosis (n=4). Therapy (including combination chemotherapy) was evaluated on Clinical course and response to therapy. In four patients with intravascular lymphomatosis, the disease showed a variable clinical course with progression and central nervous system involvement, and no consistently effective therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: